BI Office Hours offers life science companies and entrepreneurs individual attention in an informal ‘office hours’ atmosphere. Designed as a consultative ‘round table’ meeting, this pioneering mentoring initiative ‘lifts the lid’ on how a big pharma company works and it provides access to expertise, an industry perspective and feedback to emerging life-science businesses.
While deliberately not being a partnering meeting, BI Office Hours gives you direct access to BI’s management and know-how (science and business) to find out what are the critical factors a pharma partner is looking for in terms of, for example, therapeutic concept validation, ‘key’ experiments, therapeutic modalities (small molecules, antibodies, others), animal models, patient selection biomarkers, clinical development, landscape positioning, and reimbursement considerations. For more information, please see https://www.boehringer-ingelheim.com/grass-roots-partnering/office-hours/about-office-hours
We would like to invite you to apply for the next BI Office Hours to be held as a face-2-face meeting at the Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, 1030 Vienna, Austria, with the option to join online on March 7, 2023, 9 a.m. to 5 p.m.
In preparation for our discussion please kindly provide the BI Team with:
- An executive summary and/or,
- A short presentation (no more than 10 slides) outlining your technology, main features, problems it solves and any supportive scientific data
- Please include 5 key questions you would like to have answered during our brainstorming session
All information submitted must be non-confidential and provided by February 10, 2023 to the BI team. We meet with only 5-6 companies in a day, with the intent of having a one-on-one informal conversation. Since starting this program Boehringer Ingelheim has coached > 300 companies in USA, China, UK, Germany, Austria and France, all with very positive feedback.
Please let us know if you are interested in participating, we will be happy to meet you.
Dr. Guido Boehmelt
Research Beyond Borders
Boehringer Ingelheim RCV
guido.boehmelt(at)boehringer-ingelheim.com
Dr. Maria Antonietta Impagnatiello
Business Development & Licensing
Boehringer Ingelheim RCV
maria_antonietta.impagnatiello(at)boehringer-ingelheim.com